← k3vl4r
Log inGet started →

EVGN (Evogene Ltd) Price Forecast

AI-generated price forecast for Evogene Ltd (EVGN) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads EVGN as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 0.3065. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

0.3065

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

EVGN forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-62.41%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called EVGN's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest EVGN news

From the market-news feed the forecasts are read against.

  • Evogene Schedules Third Quarter 2026 Financial Results Release · Yahoo · Nov 5
  • Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program · Yahoo · Oct 28
  • Evogene Announces Acute Graft-Versus-Host Disease As Target Indication For Its Internal Drug Discovery Program · Benzinga · Oct 28
  • Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain · Yahoo · Oct 26
  • Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL · Yahoo · Oct 20

🔒

See the full EVGN forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

EVGN forecast — frequently asked

Will EVGN go up?

K3vl4r's calibrated AI forecast currently reads EVGN as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the EVGN price prediction for 2026?

K3vl4r's model projects EVGN toward $0.1081 over the next ~4 weeks, a -62.4% move from $0.2875. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

TMCICLNNORKAINMBANVSASNDLUCDCMPSAKBAOABIVNDATVTXDNTHMGTX

Will EVGN reach…?

Will EVGN reach $0.5000?Will EVGN reach $1.00?Will EVGN reach $2.00?

Or see the full EVGN price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare EVGN

EVGN vs TMCIEVGN vs CLNNEVGN vs ORKAEVGN vs INMBEVGN vs ANVSEVGN vs ASND

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.